120 related articles for article (PubMed ID: 14980780)
1. Targeted delivery of antisense oligodeoxynucleotides to folate receptor-overexpressing tumor cells.
Yang L; Li J; Zhou W; Yuan X; Li S
J Control Release; 2004 Mar; 95(2):321-31. PubMed ID: 14980780
[TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
3. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
5. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor.
Zhao XB; Lee RJ
Adv Drug Deliv Rev; 2004 Apr; 56(8):1193-204. PubMed ID: 15094215
[TBL] [Abstract][Full Text] [Related]
6. Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.
Zhou W; Yuan X; Wilson A; Yang L; Mokotoff M; Pitt B; Li S
Bioconjug Chem; 2002; 13(6):1220-5. PubMed ID: 12440856
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo.
Wilson A; Zhou W; Champion HC; Alber S; Tang ZL; Kennel S; Watkins S; Huang L; Pitt B; Li S
Mol Ther; 2005 Sep; 12(3):510-8. PubMed ID: 15953766
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
9. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
11. Improved formulations of antisense oligodeoxynucleotides using wrapped liposomes.
Yamauchi M; Kusano H; Saito E; Iwata T; Nakakura M; Kato Y; Uochi T; Akinaga S; Aoki N
J Control Release; 2006 Aug; 114(2):268-75. PubMed ID: 16860428
[TBL] [Abstract][Full Text] [Related]
12. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides.
Kim SH; Kim EJ; Hou JH; Kim JM; Choi HG; Shim CK; Oh YK
Biomaterials; 2009 Feb; 30(5):959-67. PubMed ID: 19027156
[TBL] [Abstract][Full Text] [Related]
13. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
14. Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages.
Oishi M; Nagatsugi F; Sasaki S; Nagasaki Y; Kataoka K
Chembiochem; 2005 Apr; 6(4):718-25. PubMed ID: 15756696
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
Gong ZB; Liu JM; Li YM
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
[TBL] [Abstract][Full Text] [Related]
16. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation.
Stevens PJ; Sekido M; Lee RJ
Anticancer Res; 2004; 24(1):161-5. PubMed ID: 15015592
[TBL] [Abstract][Full Text] [Related]
18. Tumour-selective drug delivery via folate receptor-targeted liposomes.
Pan X; Lee RJ
Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
[TBL] [Abstract][Full Text] [Related]
19. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells.
Lu Y; Wu J; Wu J; Gonit M; Yang X; Lee A; Xiang G; Li H; Liu S; Marcucci G; Ratnam M; Lee RJ
Mol Pharm; 2007; 4(5):707-12. PubMed ID: 17708654
[TBL] [Abstract][Full Text] [Related]
20. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
